2019
DOI: 10.1007/s00784-019-03067-9
|View full text |Cite
|
Sign up to set email alerts
|

Lithium chloride assuages bone loss in experimental periodontitis in estrogen-deficient rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
5
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 41 publications
1
5
0
Order By: Relevance
“…3). In support of these findings, previous investigations also reported that lithium chloride can increase the expression of RANKL (20,29). Nonetheless, the increased expression of RANKL that was observed, herein, during lithium treatment is somewhat surprising as bone healing was improved in the Lithium chloride group even though RANKL is a marker of osteoclastogenesis.…”
Section: Discussionsupporting
confidence: 84%
See 3 more Smart Citations
“…3). In support of these findings, previous investigations also reported that lithium chloride can increase the expression of RANKL (20,29). Nonetheless, the increased expression of RANKL that was observed, herein, during lithium treatment is somewhat surprising as bone healing was improved in the Lithium chloride group even though RANKL is a marker of osteoclastogenesis.…”
Section: Discussionsupporting
confidence: 84%
“…In fact, lithium chloride treatment increased the expression of the three markers of osteogenesis including OCN, a middle stage marker, OPN, a late stage marker and BSP, a marker of osteoblast differentiation (30). Previous studies have already revealed similar trends towards the increased expression of osteogenic/osteoblast markers in the presence of lithium chloride (16,20,(31)(32)(33). Taken together, these histometric and immunohistochemical findings suggest that lithium chloride may represent a promising pharmacological agent for bone repair in estrogen deficient status, particularly in the early to the middle healing stages.…”
Section: Discussionmentioning
confidence: 74%
See 2 more Smart Citations
“…Drugs that target more than one gene were considered more credible and effective ( Table 2 ). Some of them, including Methotrexate, Melatonin, Resveratrol, Diacerein, Lithium and Infliximab, have been used to treat periodontitis or T2DM in animal experiments ( 43 47 , 49 ), while the remaining drugs (Hydroquinone, Echinacea, Hydrocortisone, Cisplatin, Omeprazole, Ibudilast, Lansoprazole) have not been found to have therapeutic effects in periodontitis with T2DM. Notably, Cisplatin, a metal-based anticancer agent, has been reported to aggravate periodontitis ( 48 ).…”
Section: Resultsmentioning
confidence: 99%